Health Catalyst Inc（HCAT）价格预测HCATHealth Catalyst Inc

Alphio's HCAT stock price prediction model matches the current Health Catalyst Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.50 (-0.06%). The 1-week path is $1.54 (+2.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Health Catalyst Inc is not a good buy right now. The current price is $1.58, which is significantly below the 52-week high of $3.36, indicating a decline of 53.0%. Additionally, the RSI is at 34.34, suggesting that the stock is oversold. The company has reported substantial losses, with a net income of -$111 million in Q1 2026 and -$40.5 million in Q2 2026, which raises concerns about its profitability. The main risk is the ongoing uncertainty around client churn and potential down-sell risks, as highlighted by analyst downgrades.

Health Catalyst Inc (HCAT) last closed at $1.5, losing -5.66%. These facts feed the 1-day and 1-week HCAT price prediction above.